Phase I: Solid tumors
FOCUS AREA
SOLID TUMORS
DEVELOPMENT STAGE
PHASE I
TARGET
2
7
Order
14
Subtitle pipeline
Combination
SEO Description
MDM2-p53 antagonist (BI 907828) + ezabenlimab (BI 754091)